SF Medical ApS: Financial statements 2023
CVR: 36964901
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
SF Medical ApS (CVR 36964901) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -17,208 and a net result of DKK -319,608 compared with DKK -357,022 the year before. Equity in the 2023 report amounted to DKK 390,326. The solvency ratio was 96.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -17,208
- Profit/Loss
- DKK -319,608
- Equity
- DKK 390,326
- Total Assets
- DKK 405,329
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -17K | -320K | 390K | 1 |
| 2022 | - | -251K | -357K | -261K | 1 |
| 2021 | - | -209K | -333K | 96K | 1 |
| 2020 | - | -150K | -385K | 79K | 1 |
| 2019 | - | -67K | -455K | 64K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 20, 2023, Jan Ove Myklebust is registered as director of SF Medical ApS.
As of October 20, 2023, Louise Margrethe Deichmann has stepped down as adm. dir. of SF Medical ApS.
About SF Medical ApS
SF Medical ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jan Ove Myklebust. The company is owned by MYKLEBUST HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -60,396 and a net result of DKK 3,682 compared with DKK -234,262 the year before. Equity in the 2025 report amounted to DKK 159,745.